MolNFT v1 · #151411 · protein
Complex of caprine serum albumin with diclofenac
6HN1: “Complex of caprine serum albumin with diclofenac”. X-ray diffraction, 2 ligands (DIF, CL), 8 pockets (best druggability 0.81). MolNFT v1 #151411 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6HN1
- Type
- protein
- Length
- 583 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Albumin
- UniProt
- B3VHM9
- Ligands
- DIF, CL
- Pockets
- 8 · best druggability 0.81
Structure
x-ray diffraction · 1 distinct chain · 72% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Albumin | protein | 583 | 72% helix, 0% strand | B3VHM9 |
Ligands and binding sites
- DIF · 2-[2,6-dichlorophenyl)amino]benzeneacetic acid · ligand · 6 copies · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 764 | 0.81 | 0.85 | 73 | DIF, CL |
| 2 | 806 | 0.76 | 0.80 | 57 | DIF |
| 3 | 163 | 0.70 | 0.89 | 22 | DIF |
| 4 | 194 | 0.70 | 0.87 | 21 | DIF |
| 5 | 95 | 0.49 | 0.81 | 15 | DIF |
Modifications
Observed in the structure: 17 disulfide (disulfide).
Compared structures
- 6HN1 · Complex of Caprine Serum Albumin with diclofenac · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt B3VHM9
- Elsewhere: RCSB PDB 6HN1 · PDBe 6HN1 · UniProt B3VHM9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.